Prognostic interaction between clinical stage and left atrial remodeling in dogs with myxomatous mitral valve disease

Read full text
Authors: Sin-Wook Park, Keon Kim, Kyung-Ho You, Woong-Bin Ro, Chang-Min Lee
Cited by: 1
References: 28

Abstract

Myxomatous mitral valve disease (MMVD) is leading cause of acquired heart failure in small-breed dogs. Although the American College of Veterinary Internal Medicine (ACVIM) staging is widely used in practice, how each stage and the degree of cardiac remodeling affect survival has not been clearly defined. We aimed to determine whether severe remodeling in dogs with preclinical (stage B2) disease is associated with survival differences compared with dogs with congestive heart failure (CHF; stage C) and less severe remodeling. This retrospective study analyzed 270 dogs with MMVD, stratified by the left atrium-to-aortic root ratio as having mild (

Fields of Study & Subjects

Cardiovascular Conditions and Treatments Veterinary Orthopedics and Neurology Microbial infections and disease research

Publication details

Journal / source
Veterinary Quarterly
Publisher
Informa UK Limited
Volume
46
Issue
1
Pages
2668790–2668790
Publication date
6 May 2026
Language
EN